174 related articles for article (PubMed ID: 10828036)
21. Chimeric protein cytotoxic against KS tumors.
Marshall A; Castellino A
Nat Biotechnol; 1997 Apr; 15(4):304. PubMed ID: 9094112
[No Abstract] [Full Text] [Related]
22. Convection-enhanced delivery of interleukin-13 receptor-directed cytotoxin for malignant glioma therapy.
Kioi M; Husain SR; Croteau D; Kunwar S; Puri RK
Technol Cancer Res Treat; 2006 Jun; 5(3):239-50. PubMed ID: 16700620
[TBL] [Abstract][Full Text] [Related]
23. Interleukin-4 receptor expression on AIDS-associated Kaposi's sarcoma cells and their targeting by a chimeric protein comprised of circularly permuted interleukin-4 and Pseudomonas exotoxin.
Husain SR; Gill P; Kreitman RJ; Pastan I; Puri RK
Mol Med; 1997 May; 3(5):327-38. PubMed ID: 9205948
[TBL] [Abstract][Full Text] [Related]
24. Complete regression of established human glioblastoma tumor xenograft by interleukin-4 toxin therapy.
Husain SR; Behari N; Kreitman RJ; Pastan I; Puri RK
Cancer Res; 1998 Aug; 58(16):3649-53. PubMed ID: 9721874
[TBL] [Abstract][Full Text] [Related]
25. Pancreatic cancer cells express interleukin-13 and -4 receptors, and their growth is inhibited by Pseudomonas exotoxin coupled to interleukin-13 and -4.
Kornmann M; Kleeff J; Debinski W; Korc M
Anticancer Res; 1999; 19(1A):125-31. PubMed ID: 10226533
[TBL] [Abstract][Full Text] [Related]
26. Sensitization of cancer cells to interleukin 13-pseudomonas exotoxin-induced cell death by gene transfer of interleukin 13 receptor alpha chain.
Kawakami K; Joshi BH; Puri RK
Hum Gene Ther; 2000 Sep; 11(13):1829-35. PubMed ID: 10986556
[TBL] [Abstract][Full Text] [Related]
27. Analysis of target genes induced by IL-13 cytotoxin in human glioblastoma cells.
Han J; Yang L; Puri RK
J Neurooncol; 2005 Mar; 72(1):35-46. PubMed ID: 15803373
[TBL] [Abstract][Full Text] [Related]
28. Analysis of antitumor activity of an interleukin-13 (IL-13) receptor-targeted cytotoxin composed of IL-13 antagonist and Pseudomonas exotoxin.
Kioi M; Kawakami K; Puri RK
Clin Cancer Res; 2004 Sep; 10(18 Pt 1):6231-8. PubMed ID: 15448012
[TBL] [Abstract][Full Text] [Related]
29. Human adrenomedullin up-regulates interleukin-13 receptor alpha2 chain in prostate cancer in vitro and in vivo: a novel approach to sensitize prostate cancer to anticancer therapy.
Joshi BH; Leland P; Calvo A; Green JE; Puri RK
Cancer Res; 2008 Nov; 68(22):9311-7. PubMed ID: 19010904
[TBL] [Abstract][Full Text] [Related]
30. Interleukin 13 mediates signal transduction through interleukin 13 receptor alpha2 in pancreatic ductal adenocarcinoma: role of IL-13 Pseudomonas exotoxin in pancreatic cancer therapy.
Shimamura T; Fujisawa T; Husain SR; Joshi B; Puri RK
Clin Cancer Res; 2010 Jan; 16(2):577-86. PubMed ID: 20068108
[TBL] [Abstract][Full Text] [Related]
31. Interleukin-4 receptor cytotoxin as therapy for human malignant pleural mesothelioma xenografts.
Beseth BD; Cameron RB; Leland P; You L; Varricchio F; Kreitman RJ; Maki RA; Jablons DM; Husain SR; Puri RK
Ann Thorac Surg; 2004 Aug; 78(2):436-43; discussion 436-43. PubMed ID: 15276492
[TBL] [Abstract][Full Text] [Related]
32. IL-13 fusion cytotoxin ameliorates chronic fungal-induced allergic airway disease in mice.
Blease K; Jakubzick C; Schuh JM; Joshi BH; Puri RK; Hogaboam CM
J Immunol; 2001 Dec; 167(11):6583-92. PubMed ID: 11714828
[TBL] [Abstract][Full Text] [Related]
33. Tumor regression mechanisms by IL-13 receptor-targeted cancer therapy involve apoptotic pathways.
Kawakami M; Kawakami K; Puri RK
Int J Cancer; 2003 Jan; 103(1):45-52. PubMed ID: 12455052
[TBL] [Abstract][Full Text] [Related]
34. Combined effects of radiation and interleukin-13 receptor-targeted cytotoxin on glioblastoma cell lines.
Kawakami K; Kawakami M; Liu Q; Puri RK
Int J Radiat Oncol Biol Phys; 2005 Sep; 63(1):230-7. PubMed ID: 16111594
[TBL] [Abstract][Full Text] [Related]
35. Intratumoral therapy with IL13-PE38 results in effective CTL-mediated suppression of IL-13Ralpha2-expressing contralateral tumors.
Kawakami K; Terabe M; Kioi M; Berzofsky JA; Puri RK
Clin Cancer Res; 2006 Aug; 12(15):4678-86. PubMed ID: 16899618
[TBL] [Abstract][Full Text] [Related]
36. Neuroradiographic changes following convection-enhanced delivery of the recombinant cytotoxin interleukin 13-PE38QQR for recurrent malignant glioma.
Parney IF; Kunwar S; McDermott M; Berger M; Prados M; Cha S; Croteau D; Puri RK; Chang SM
J Neurosurg; 2005 Feb; 102(2):267-75. PubMed ID: 15739554
[TBL] [Abstract][Full Text] [Related]
37. Inhibition of AIDS-associated Kaposi's sarcoma cell growth by DAB389-interleukin 6.
Masood R; Lunardi-Iskandar Y; Jean LF; Murphy JR; Waters C; Gallo RC; Gill P
AIDS Res Hum Retroviruses; 1994 Aug; 10(8):969-75. PubMed ID: 7811548
[TBL] [Abstract][Full Text] [Related]
38. Preclinical development of a recombinant toxin containing circularly permuted interleukin 4 and truncated Pseudomonas exotoxin for therapy of malignant astrocytoma.
Puri RK; Hoon DS; Leland P; Snoy P; Rand RW; Pastan I; Kreitman RJ
Cancer Res; 1996 Dec; 56(24):5631-7. PubMed ID: 8971168
[TBL] [Abstract][Full Text] [Related]
39. AIDS-associated Kaposi's sarcoma (KS) cells express oncostatin M (OM)-specific receptor but not leukemia inhibitory factor/OM receptor or interleukin-6 receptor. Complete block of OM-induced KS cell growth and OM binding by anti-gp130 antibodies.
Murakami-Mori K; Taga T; Kishimoto T; Nakamura S
J Clin Invest; 1995 Sep; 96(3):1319-27. PubMed ID: 7657807
[TBL] [Abstract][Full Text] [Related]
40. IL-4 receptor-directed cytotoxin for therapy of AIDS-associated KS tumors.
Puri RK
Drug News Perspect; 2000 Sep; 13(7):395-402. PubMed ID: 12937611
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
